- Home
- EDSA vs UCAR Comparison
EDSA vs UCAR Comparison
Compare EDSA & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- UCAR
- Stock Information
- Founded
- EDSA 2015
- UCAR 2013
- Country
- EDSA Canada
- UCAR China
- Employees
- EDSA N/A
- UCAR N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- UCAR Retail-Auto Dealers and Gas Stations
- Sector
- EDSA Health Care
- UCAR Consumer Discretionary
- Exchange
- EDSA Nasdaq
- UCAR Nasdaq
- Market Cap
- EDSA 13.8M
- UCAR 13.3M
- IPO Year
- EDSA N/A
- UCAR 2023
- Fundamental
- Price
- EDSA $2.10
- UCAR $3.82
- Analyst Decision
- EDSA Strong Buy
- UCAR
- Analyst Count
- EDSA 2
- UCAR 0
- Target Price
- EDSA $13.00
- UCAR N/A
- AVG Volume (30 Days)
- EDSA 13.1K
- UCAR 104.7K
- Earning Date
- EDSA 08-08-2025
- UCAR 07-22-2025
- Dividend Yield
- EDSA N/A
- UCAR N/A
- EPS Growth
- EDSA N/A
- UCAR N/A
- EPS
- EDSA N/A
- UCAR N/A
- Revenue
- EDSA N/A
- UCAR $6,067,871.00
- Revenue This Year
- EDSA N/A
- UCAR N/A
- Revenue Next Year
- EDSA N/A
- UCAR N/A
- P/E Ratio
- EDSA N/A
- UCAR N/A
- Revenue Growth
- EDSA N/A
- UCAR 124.09
- 52 Week Low
- EDSA $1.55
- UCAR $2.30
- 52 Week High
- EDSA $5.59
- UCAR $9.43
- Technical
- Relative Strength Index (RSI)
- EDSA 60.43
- UCAR 48.22
- Support Level
- EDSA $2.05
- UCAR $3.44
- Resistance Level
- EDSA $2.17
- UCAR $3.92
- Average True Range (ATR)
- EDSA 0.09
- UCAR 0.49
- MACD
- EDSA 0.02
- UCAR -0.08
- Stochastic Oscillator
- EDSA 96.30
- UCAR 20.24
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.